Skip to main content
Clinical Trials/ISRCTN57028065
ISRCTN57028065
Active, not recruiting
未知

Towards a patient supported, well-tolerated and evidence-based home-based treatment program to improve quality of life and swallowing function in head and neck cancer survivors with chronic radiation-associated dysphagia treated with chemoradiotherapy: a multicentre randomised controlled trial

Antwerp University Hospital0 sites105 target enrollmentJuly 15, 2021

Overview

Phase
未知
Intervention
Not specified
Conditions
Signs and Symptoms
Sponsor
Antwerp University Hospital
Enrollment
105
Status
Active, not recruiting
Last Updated
3 years ago

Overview

Brief Summary

2022 Protocol article in https://pubmed.ncbi.nlm.nih.gov/36273210/ (added 24/10/2022)

Registry
who.int
Start Date
July 15, 2021
End Date
January 1, 2025
Last Updated
3 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Patients with a history of head and neck cancer treated with radiotherapy or chemoradiotherapy
  • 2\. Diagnosis of C\-RAD, present for at least 3 months, based on the EAT\-10 (score \=3\) and/or FOIS (max level 6 out of 7\)
  • 3\. Eligible tumour sites: oral cavity, oropharynx, larynx, hypopharynx and nasopharynx
  • 4\. At least 6 months post\-treatment

Exclusion Criteria

  • 1\. History of major surgery within the head and neck region
  • 2\. Recurrent carcinoma in the head and neck region
  • 3\. Neurological history that might adversely affect cognition, muscle strength in the head and neck region or swallowing function
  • 4\. Dysphagia prior to CRT
  • 5\. Intensive swallowing therapy (\> once per week) in the last 6 months
  • 6\. Complete dependency on tube feeding during more than 1 year
  • 7\. Severe frailty or worse following the Clinical Frailty Scale (CFS) (\=7\)
  • 8\. Related to HD\-tDCS: presence of implanted metal or electronic medical devices in the brain or other sites in the body (e.g. deep brain stimulator, cochlear Implant, pacemaker) except for dental implants, history of migraine, epilepsy, brain damage (stroke) or head trauma followed by impairment or consciousness, skin problems (e.g. dermatitis, psoriasis) and use of medication that interferes with non\-invasive brain stimulation

Outcomes

Primary Outcomes

Not specified

Similar Trials